Two Bipartisan Bills Aim to Encourage Competition in the Biopharma Industry
By EsqSocial Corporation 25/05/21
Drug pricing and innovation are hot topics in Washington right now with several bills making their way through the legislative process, many in a bipartisan fashion. On April 23, 2021, two of these bills were signed into law by President Biden. The first bill, the Ensuring Innovation Act, limits new drug exclusivity, thereby making it easier for generics to enter the market and spur competition. The second bill, the Advancing Education on Biosimilars Act of 2021, is designed to increase the...
By: Kilpatrick Townsend & Stockton LLP